108 related articles for article (PubMed ID: 20386703)
1. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.
Schildkraut JM; Iversen ES; Wilson MA; Clyde MA; Moorman PG; Palmieri RT; Whitaker R; Bentley RC; Marks JR; Berchuck A
PLoS One; 2010 Apr; 5(4):e10061. PubMed ID: 20386703
[TBL] [Abstract][Full Text] [Related]
2. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
Kar SP; Tyrer JP; Li Q; Lawrenson K; Aben KK; Anton-Culver H; Antonenkova N; Chenevix-Trench G; ; ; Baker H; Bandera EV; Bean YT; Beckmann MW; Berchuck A; Bisogna M; Bjørge L; Bogdanova N; Brinton L; Brooks-Wilson A; Butzow R; Campbell I; Carty K; Chang-Claude J; Chen YA; Chen Z; Cook LS; Cramer D; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Dürst M; Eccles D; Easton DF; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Grownwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall E; Hogdall CK; Hosono S; Iversen ES; Jakubowska A; Paul J; Jensen A; Ji BT; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley J; Kiemeney LA; Krakstad C; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger L; Matsuo K; McGuire V; McLaughlin JR; McNeish IA; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Nevanlinna H; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Phelan CM; Pike MC; Poole EM; Ramus SJ; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schildkraut JM; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Sucheston-Campbell LE; Tangen IL; Teo SH; Terry KL; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; van Altena AM; Van Nieuwenhuysen E; Vergote I; Vierkant RA; Wang-Gohrke S; Walsh C; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Woo YL; Wu X; Wu A; Yang H; Zheng W; Ziogas A; Sellers TA; Monteiro AN; Freedman ML; Gayther SA; Pharoah PD
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1574-84. PubMed ID: 26209509
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
Johnatty SE; Beesley J; Chen X; Macgregor S; Duffy DL; Spurdle AB; deFazio A; Gava N; Webb PM; Rossing MA; Doherty JA; Goodman MT; Lurie G; Thompson PJ; Wilkens LR; Ness RB; Moysich KB; Chang-Claude J; Wang-Gohrke S; Cramer DW; Terry KL; Hankinson SE; Tworoger SS; Garcia-Closas M; Yang H; Lissowska J; Chanock SJ; Pharoah PD; Song H; Whitemore AS; Pearce CL; Stram DO; Wu AH; Pike MC; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Anton-Culver H; Ziogas A; Hogdall E; Kjaer SK; Hogdall C; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Phelan CM; Sellers TA; Cunningham JM; Vierkant RA; Rider DN; Goode EL; Haviv I; Chenevix-Trench G; ; ;
PLoS Genet; 2010 Jul; 6(7):e1001016. PubMed ID: 20628624
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in apoptosis pathway and the risk of ovarian cancer.
Xie H; Tao W; Wu X; Gu J
Oncotarget; 2016 Aug; 7(35):56737-56745. PubMed ID: 27462919
[TBL] [Abstract][Full Text] [Related]
5. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.
Charbonneau B; Block MS; Bamlet WR; Vierkant RA; Kalli KR; Fogarty Z; Rider DN; Sellers TA; Tworoger SS; Poole E; Risch HA; Salvesen HB; Kiemeney LA; Baglietto L; Giles GG; Severi G; Trabert B; Wentzensen N; Chenevix-Trench G; ; Whittemore AS; Sieh W; Chang-Claude J; Bandera EV; Orlow I; Terry K; Goodman MT; Thompson PJ; Cook LS; Rossing MA; Ness RB; Narod SA; Kupryjanczyk J; Lu K; Butzow R; Dörk T; Pejovic T; Campbell I; Le ND; Bunker CH; Bogdanova N; Runnebaum IB; Eccles D; Paul J; Wu AH; Gayther SA; Hogdall E; Heitz F; Kaye SB; Karlan BY; Anton-Culver H; Gronwald J; Hogdall CK; Lambrechts D; Fasching PA; Menon U; Schildkraut J; Pearce CL; Levine DA; Kjaer SK; Cramer D; Flanagan JM; Phelan CM; Brown R; Massuger LF; Song H; Doherty JA; Krakstad C; Liang D; Odunsi K; Berchuck A; Jensen A; Lubinski J; Nevanlinna H; Bean YT; Lurie G; Ziogas A; Walsh C; Despierre E; Brinton L; Hein A; Rudolph A; Dansonka-Mieszkowska A; Olson SH; Harter P; Tyrer J; Vitonis AF; Brooks-Wilson A; Aben KK; Pike MC; Ramus SJ; Wik E; Cybulski C; Lin J; Sucheston L; Edwards R; McGuire V; Lester J; du Bois A; Lundvall L; Wang-Gohrke S; Szafron LM; Lambrechts S; Yang H; Beckmann MW; Pelttari LM; Van Altena AM; van den Berg D; Halle MK; Gentry-Maharaj A; Schwaab I; Chandran U; Menkiszak J; Ekici AB; Wilkens LR; Leminen A; Modugno F; Friel G; Rothstein JH; Vergote I; Garcia-Closas M; Hildebrandt MA; Sobiczewski P; Kelemen LE; Pharoah PD; Moysich K; Knutson KL; Cunningham JM; Fridley BL; Goode EL
Cancer Res; 2014 Feb; 74(3):852-61. PubMed ID: 24272484
[TBL] [Abstract][Full Text] [Related]
6. TP53 genetic polymorphisms, interactions with lifestyle factors and lung cancer risk: a case control study in a Chinese population.
Li Y; Chang SC; Niu R; Liu L; Crabtree-Ide CR; Zhao B; Shi J; Han X; Li J; Su J; Cai L; Yu S; Zhang ZF; Mu L
BMC Cancer; 2013 Dec; 13():607. PubMed ID: 24369748
[TBL] [Abstract][Full Text] [Related]
7. New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions.
Zhang C; Sheng Y; Sun X; Wang Y
Cancer Metastasis Rev; 2023 Sep; 42(3):891-925. PubMed ID: 37368179
[TBL] [Abstract][Full Text] [Related]
8. Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.
Hurwitz LM; Webb PM; Jordan SJ; Doherty JA; Harris HR; Goodman MT; Shvetsov YB; Modugno F; Moysich KB; Schildkraut JM; Berchuck A; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Wu AH; Pearce CL; Wentzensen N; Tworoger SS; Pharoah PDP; Trabert B
JAMA Netw Open; 2023 Feb; 6(2):e230666. PubMed ID: 36826816
[TBL] [Abstract][Full Text] [Related]
9. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; McGuire V; McLaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; ; Risch HA; Modugno F
J Natl Cancer Inst; 2023 May; 115(5):539-551. PubMed ID: 36688720
[TBL] [Abstract][Full Text] [Related]
10. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia.
Hurwitz LM; Townsend MK; Jordan SJ; Patel AV; Teras LR; Lacey JV; Doherty JA; Harris HR; Goodman MT; Shvetsov YB; Modugno F; Moysich KB; Robien K; Prizment A; Schildkraut JM; Berchuck A; Fortner RT; Chan AT; Wentzensen N; Hartge P; Sandler DP; O'Brien KM; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Pearce CL; Wu AH; White E; Peters U; Webb PM; Tworoger SS; Trabert B
J Clin Oncol; 2022 Dec; 40(36):4207-4217. PubMed ID: 35867953
[TBL] [Abstract][Full Text] [Related]
11. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.
Brieger KK; Phung MT; Mukherjee B; Bakulski KM; Anton-Culver H; Bandera EV; Bowtell DDL; Cramer DW; DeFazio A; Doherty JA; Fereday S; Fortner RT; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Matsuo K; Menon U; Modugno F; Moysich KB; Qin B; Ramus SJ; Risch HA; Rossing MA; Schildkraut JM; Trabert B; Vierkant RA; Winham SJ; Wentzensen N; Wu AH; Ziogas A; Khoja L; Cho KR; McLean K; Richardson J; Grout B; Chase A; Deurloo CM; Odunsi K; Nelson BH; Brenton JD; Terry KL; Pharoah PDP; Berchuck A; Hanley GE; Webb PM; Pike MC; Pearce CL;
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):443-452. PubMed ID: 34789471
[TBL] [Abstract][Full Text] [Related]
12. The repair gene
Muhseena N K; Mathukkada S; Das SP; Laha S
Oncol Rev; 2021 Feb; 15(1):519. PubMed ID: 34322202
[No Abstract] [Full Text] [Related]
13. Association Between Single-Nucleotide Polymorphisms in Breast Cancer Susceptibility Genes and Clinicopathological Characteristics.
Wang S; Zhang K; Tang L; Yang Y; Wang H; Zhou Z; Pang J; Chen F
Clin Epidemiol; 2021; 13():103-112. PubMed ID: 33623437
[TBL] [Abstract][Full Text] [Related]
14. Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.
Phung MT; Lee AW; Wu AH; Berchuck A; Cho KR; Cramer DW; Doherty JA; Goodman MT; Hanley GE; Harris HR; McLean K; Modugno F; Moysich KB; Mukherjee B; Schildkraut JM; Terry KL; Titus LJ; Jordan SJ; Webb PM; Pike MC; Pearce CL; ; ;
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):927-935. PubMed ID: 33619020
[TBL] [Abstract][Full Text] [Related]
15. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.
Modugno F; Fu Z; Jordan SJ; Group A; Chang-Claude J; Fortner RT; Goodman MT; Moysich KB; Schildkraut JM; Berchuck A; Bandera EV; Qin B; Sutphen R; McLaughlin JR; Menon U; Ramus SJ; Gayther SA; Gentry-Maharaj A; Karpinskyj C; Pearce CL; Wu AH; Risch HA; Webb PM
Eur J Epidemiol; 2020 Nov; 35(11):1025-1042. PubMed ID: 32959149
[TBL] [Abstract][Full Text] [Related]
16. Histotype classification of ovarian carcinoma: A comparison of approaches.
Peres LC; Cushing-Haugen KL; Anglesio M; Wicklund K; Bentley R; Berchuck A; Kelemen LE; Nazeran TM; Gilks CB; Harris HR; Huntsman DG; Schildkraut JM; Rossing MA; Köbel M; Doherty JA
Gynecol Oncol; 2018 Oct; 151(1):53-60. PubMed ID: 30121132
[TBL] [Abstract][Full Text] [Related]
17. DNA damage repair in ovarian cancer: unlocking the heterogeneity.
Gee ME; Faraahi Z; McCormick A; Edmondson RJ
J Ovarian Res; 2018 Jun; 11(1):50. PubMed ID: 29925418
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.
Ugai T; Kelemen LE; Mizuno M; Ong JS; Webb PM; Chenevix-Trench G; ; Wicklund KG; Doherty JA; Rossing MA; Thompson PJ; Wilkens LR; Carney ME; Goodman MT; Schildkraut JM; Berchuck A; Cramer DW; Terry KL; Cai H; Shu XO; Gao YT; Xiang YB; Van Den Berg D; Pike MC; Wu AH; Pearce CL; Matsuo K;
Cancer Sci; 2018 Feb; 109(2):435-445. PubMed ID: 29247577
[TBL] [Abstract][Full Text] [Related]
19. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
Peres LC; Risch H; Terry KL; Webb PM; Goodman MT; Wu AH; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Manichaikul A; Abbott SE; Camacho F; Jordan SJ; Nagle CM; ; Rossing MA; Doherty JA; Modugno F; Moysich K; Ness R; Berchuck A; Cook L; Le N; Brooks-Wilson A; Sieh W; Whittemore A; McGuire V; Rothstein J; Anton-Culver H; Ziogas A; Pearce CL; Tseng C; Pike M; Schildkraut JM;
Int J Epidemiol; 2018 Apr; 47(2):460-472. PubMed ID: 29211900
[TBL] [Abstract][Full Text] [Related]
20. Regulatory network involving miRNAs and genes in serous ovarian carcinoma.
Zhao H; Xu H; Xue L
Oncol Lett; 2017 Nov; 14(5):6259-6268. PubMed ID: 29113276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
